Although we could not find association between visfatin serum levels and metabolic syndrome in RA patients with severe disease undergoing anti-TNF-α therapy [66], we observed a positive correlation between visfatin serum levels and IR in AS [56]. This evidence concerns the gene NAMPT and metabolic syndrome.